New research suggests that patients who stop using popular GLP-1 drugs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who stop conventional diet and exercise plans.
Published data in a major health publication shows that while overweight individuals frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users buying these treatments must be cognizant of the potential of quick weight regain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a return to starting weight in about a year and a half.
Weighing Treatments
The analysis, which looked at 37 of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers point out that people who lose weight through dieting usually see a slower creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Nutrition scientists propose the mode of action of the drugs is key to understanding the heightened rebound.
GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing the hormone levels far above than normal could lead to the body to produce less of its own natural hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement results in appetite is unsuppressed, making excessive eating far more likely."
An Ongoing Issue?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, given the high risk of relapse, the therapy is often ongoing.
This perspective is echoed by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have come off the jabs explain a sudden resurgence of hunger.
"It felt as if a switch activating and you're instantly starving," described one woman.
This challenge is worsened if users have not developed sustainable lifestyle or habit modifications during treatment.
Widespread Adoption
Figures show that millions of people in the UK have used these injections in the past year, with interest being substantial.
- Adoption is more common among females compared to men.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, experts caution that while these medications are powerful agents for weight loss, they are not a standalone fix and lasting health benefits relies on ongoing lifestyle changes.
